Pre-operative immunotherapy with tumor cryoablation (cryo) plus ipilimumab (ipi) induces potentially favorable systemic and intratumoral immune effects in early stage breast cancer (ESBC) patients

類似資料

• Matched T cell repertoire analysis of peripheral blood and tumor-infiltrating lymphocytes (TILs) in early stage breast cancer (ESBC) patients (pts) treated with pre-operative cryoablation (cryo) and/or Ipilimumab (Ipi)
  著者:: Page, David B, 等
  出版事項: (2014)
• A pilot study of preoperative single-dose ipilimumab and/or cryoablation in women with early- stage breast cancer with comprehensive immune profiling
  著者:: McArthur, Heather L., 等
  出版事項: (2016)
• Immuno-oncology safety education experience: Key lessons from ipilimumab (IPI)
  著者:: Bartell, Heddy, 等
  出版事項: (2015)
• Pilot study of intratumoral (IT) cryoablation (cryo) in combination with systemic checkpoint blockade in patients with metastatic melanoma (MM)
  著者:: Kim, Dae Won, 等
  出版事項: (2015)
• Patterns of long-term survival following Ipilimumab (Ipi): the Memorial Sloan Kettering Cancer Center 10-year metastatic melanoma (MM) experience
  著者:: Page, David B, 等
  出版事項: (2014)